The impact of blood flow rate during hemodialysis on all-cause mortality
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Inadequacy of dialysis is associated with morbidity and mortality in chronic hemodialysis (HD) patients. Blood flow rate (BFR) during HD is one of the important determinants of increasing dialysis dose. However, the optimal BFR is unclear. In this study, we investigated the impact of the BFR on allcause mortality in chronic HD patients. Methods: Prevalent HD patients were selected from Clinical Research Center registry for end-stage renal disease cohort in Korea. We categorized patients into two groups by BFR < 250 and ≥ 250 mL/min according to the median value of BFR 250 mL/min in this study. The primary outcome was all-cause mortality. Results: A total of 1,129 prevalent HD patients were included. The number of patients in the BFR < 250 mL/min was 271 (24%) and in the BFR ≥ 250 mL/min was 858 (76%). The median follow-up period was 30 months. Kaplan-Meier analysis showed that the mortality rate was significantly higher in patients with BFR < 250 mL/min than those with BFR ≥ 250 mL/min (p = 0.042, log-rank). In the multivariate Cox regression analyses, patients with BFR < 250 mL/min had higher allcause mortality than those with BFR ≥ 250 mL/min (hazard ratio, 1.66; 95% confidence interval, 1.00 to 2.73; p = 0.048). Conclusions: Our data showed that BFR < 250 mL/min during HD was associated with higher all-cause mortality in chronic HD patients.
Abstract
Background/Aims: Inadequacy of dialysis is associated with morbidity and mortality in chronic hemodialysis (HD) patients. Blood flow rate (BFR) during HD is one of the important determinants of increasing dialysis dose. However, the optimal BFR is unclear. In this study, we investigated the impact of the BFR on allcause mortality in chronic HD patients. Methods: Prevalent HD patients were selected from Clinical Research Center registry for end-stage renal disease cohort in Korea. We categorized patients into two groups by BFR < 250 and ≥ 250 mL/min according to the median value of BFR 250 mL/min in this study. The primary outcome was all-cause mortality. Results: A total of 1,129 prevalent HD patients were included. The number of patients in the BFR < 250 mL/min was 271 (24%) and in the BFR ≥ 250 mL/min was 858 (76%). The median follow-up period was 30 months. Kaplan-Meier analysis showed that the mortality rate was significantly higher in patients with BFR < 250 mL/min than those with BFR ≥ 250 mL/min (p = 0.042, log-rank). In the multivariate Cox regression analyses, patients with BFR < 250 mL/min had higher allcause mortality than those with BFR ≥ 250 mL/min (hazard ratio, 1.66; 95% confidence interval, 1.00 to 2.73; p = 0.048). Conclusions: Our data showed that BFR < 250 mL/min during HD was associated with higher all-cause mortality in chronic HD patients.
참고문헌 (15)
- Held PJ, "The dose of hemodialysis and patient mortality", Kidney Int, 50, pp.550~556 (1996)
- Mandolfo S, "How to improve dialysis adequacy in patients with vascular access problems", J Vasc Access, 7, pp.53~59 (2006)
- Jadoul M, "Modifiable practices associated with sudden death among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study", Clin J Am Soc Nephrol, 7, pp.765~774 (2012)
- Singh S, "Ten-year patient survival on maintenance haemodialysis: association with treatment time and dialysis dose", J Nephrol, 26, pp.763~770 (2013)
- Hassell DR, "Optimizing dialysis dose by increasing blood flow rate in patients with reduced vascular-access flow rate", Am J Kidney Dis, 38, pp.948~955 (2001)
- Kimata N, "Gender, low Kt", V, and mortality in Japanese hemodialysis patients: opportunities for improvement through modifiable practices, 2014, pp.18, 596~606
- Tentori F, "Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)", Nephrol Dial Transplant, 27, pp.4180~4188 (2012)
- Pisoni RL, "Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis", Am J Kidney Dis, 53, pp.475~491 (2009)
- "DOPPS practice monitor" (2015)[URL]
- Bloembergen WE, "Relationship of dose of hemodialysis and cause-specific mortality", Kidney Int, 50, pp.557~565 (1996)
- Borzou SR, "The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients", Saudi J Kidney Dis Transpl, 20, pp.639~642 (2009)
- Kim YO, "The effect of increasing blood flow rate on dialysis adequacy in hemodialysis patients with low Kt", V, 2004, pp.8, 85~
- Eknoyan G, "Effect of dialysis dose and membrane flux in maintenance hemodialysis", N Engl J Med, 347, pp.2010~2019 (2002)
- Gutzwiller JP, "Increasing blood flow increases kt", V(urea)and potassium removal but fails to improve phosphate removal, 2003, pp.59, 130~136
- Vanholder R, "Once upon a time in dialysis: the last days of Kt", V?, 2015, pp.88, 460~465